Cardiovascular Medicine and Haematology articles for Johns Hopkins University (JHU), United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 70

Article ‘Count’ for Cardiovascular Medicine and Haematology.

Journal Count Share
1 0.02
The ICE-AFIB trial: A multicenter prospective investigational device exemption (IDE) trial using cryosurgical ablation for atrial fibrillation during concomitant cardiac surgery 0.02
1 0.87
Obstructive sleep apnea and functional hearing loss over 8 years: results from the National Health and Aging Trends Study 0.87
8 2.20
Post-Tuberculosis Lung Disease in Treated Extra-Pulmonary Tuberculosis 0.78
CES1 Deficiency is Associated With Metabolic Reprograming and Endothelial Dysfunction in Pulmonary Arterial Hypertension 0.02
Motivational Interviewing and Air Cleaners for Smokers with COPD (MOVE): A Randomized, Double-Blind, Placebo-Controlled Trial 1.00
Mucus plugs in chronic obstructive pulmonary disease are heterogeneous in size and shape and occur in relatively large airways 0.06
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry Analysis. 0.07
Associations of Prepandemic Lung Function and Structure with COVID-19 Outcomes: The C4R Study 0.08
Deep Learning Estimation of Small Airway Disease from Inspiratory Chest Computed Tomography: Clinical Validation, Repeatability, and Associations with Adverse Clinical Outcomes in Chronic Obstructive Pulmonary Disease 0.05
Metabolomic Evidence of Biological Overlap with HFpEF in a Subset of Pulmonary Arterial Hypertension. 0.14
3 0.14
Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma 0.02
Rapid ADAMTS13 activity assays for thrombotic thrombocytopenic purpura: a systematic review and meta-analysis 0.07
A controlled trial for preventing priapism in sickle cell anemia: hydroxyurea plus placebo vs hydroxyurea plus tadalafil 0.05
1 0.09
A comparison of women and men with small abdominal aortic aneurysms 0.09
6 2.81
Three-Year Outcomes of Proximal Hypoglossal Nerve Stimulation in OSA 0.11
Imaging-based Pulmonary Hypertension Phenotypes in Connective Tissue Disease-related Interstitial Lung Disease 0.83
The Minimal Important Difference in N-Terminal Pro-Brain Natriuretic Peptide in Pulmonary Hypertension 0.67
Treatment patterns in incident pulmonary hypertension patients: real-world data from the Pulmonary Hypertension Association Registry 0.22
Initial Evaluation of the Pulmonary Hypertension Functional Classification Self-Report (PH-FC-SR) Measurement Properties: A Patient-Focused Measure 0.10
The Impact of the Unknown: Patient Experiences with Uncertainty in Sarcoidosis 0.88
6 1.35
Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study. 0.36
Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension. 0.14
Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort Collaboration. 0.20
Natural History of Patients With Histologically Proven Acute Eosinophilic Myocarditis. 0.02
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants. 0.16
Family Screening in Relatives at Risk for Plakophilin-2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy. 0.46
2 0.22
Socioeconomic Factors and Initiation of Semaglutide or Tirzepatide Among Medicare Beneficiaries With Type 2 Diabetes. 0.14
Racial Inequity in Prescription of Semaglutide Among Eligible People With HIV 0.08
2 0.64
Impacts from Sector-Specific Energy Policies on Mortality Co-Benefits and Socioeconomic Disparities Across Three Midwestern States in the Year 2050 0.14
Impact of Ambient Ozone Exposure on Cardiac Biomarkers in Heart Failure and the Role of Sodium-glucose Cotransporter-2 Inhibitors: Findings from the TRACER-HF Trial 0.50
1 0.11
Human Health Impacts of Energy Transitions across the United States among Sociodemographic Subpopulations for the Year 2050 0.11
4 0.33
Sex differences in cardiovascular–kidney–metabolic syndrome: the FINE-HEART pooled analysis 0.03
Aspirin use, lipoprotein(a), and calcific aortic valve disease: the Multi-ethnic Study of Atherosclerosis 0.16
Titin-related familial dilated cardiomyopathy: factors associated with disease onset 0.03
Low-density lipoprotein cholesterol and cardiovascular risk in the absence of calcifications on computed tomography: the Western Denmark Heart Registry 0.12
2 0.29
Metformin and Time to Sustained Recovery in Adults With COVID-19 0.04
Diseases Common in Persons With Cystic Fibrosis Among CFTR Heterozygotes 0.25
2 0.20
Cryobiopsy vs Forceps for Bronchoscopic Lung Biopsy: The FROSTBITE-2 Randomized Clinical Trial. 0.19
Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy 0.01
1 1.00
Loss of O-GlcNAcylation in cardiac myocytes triggers the integrated stress response, contributing to heart 1.00
1 0.07
Cilia-independent gas-liquid transport, a third mechanism mediating airway mucus clearance 0.07
1 0.06
Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. 0.06
2 0.75
A model of β‐adrenergic stimulation in human ventricular cells for tissue‐scale simulations of sympathetically modulated tachycardias 0.50
Evidence for acid‐sensing ion channel 3 (ASIC3) involvement in cough resulting from aspiration of gastric fluid 0.25
5 0.25
Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus 0.05
Use of Coronary Artery Calcium Scoring in Individuals With Elevated Lipoprotein(a) 0.04
Pulsed-Field Ablation to Enhance the Durability of Pulmonary Vein Isolation and Treat Paroxysmal Atrial Fibrillation 0.04
Association of Lipoprotein(a) and Interleukin-6 With Cardiovascular Risk MESA and UK Biobank 0.13
Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US 0.00
1 0.06
Loop Diuretic Dose Intensification versus Adjuvant Thiazide for Diuretic Resistance in Acute Heart Failure: Mechanistic Randomized Controlled Trial. 0.06
2 0.85
Deployment to Karshi-Khanabad Air Base, Uzbekistan between 2001 and 2005 and subsequent risk of specific cancers among US service members 0.81
Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer prevention 0.04
3 0.30
Risk factors for mortality in patients with kidney failure on hemodialysis identified by proteomic analysis of CRIC and PACE studies 0.10
Multi-cohort high-dimensional proteomics reveals early risk markers for lymphoid cancer subtypes 0.18
Association between self-reported multimorbidity and longitudinal brain Aβ deposition in Alzheimer’s disease 0.02
4 0.14
Pulsed Field Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation: 4-Year Outcomes in the Study 0.03
Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study 0.00
Antibody-mediated LOX-1 inhibition in patients with residual inflammation after myocardial infarction: a randomized phase 2 trial 0.04
Performance of the American Heart Association’s PREVENT risk score for cardiovascular risk prediction in a multiethnic population 0.08
2 1.08
CT Emphysema and Deep Learning-derived Vertebral Bone Loss in Individuals without COPD: Findings from MESA. 0.38
Left-to-Right Chamber Volume Ratios at Cardiac MRI Predict Cardiac Events: A Multi-Ethnic Study of Atherosclerosis Secondary Analysis. 0.70
1 0.52
Severe obesity in human HFpEF alters contractile protein function and organization 0.52
1 0.01
Engraftment and persistence of HBB base-edited hematopoietic stem cells in nonhuman primates 0.01
4 1.13
Early life peanut oral immunotherapy associated with long-term ingestion and immunologic changes 0.20
Blood neutrophil genetics highlight the role of neutrophils in early childhood asthma and viral respiratory illnesses 0.00
Club Cell RhoA Activation Amplifies Allergic Airway Inflammation by Regulating Epithelial Integrity and C1qα+ Interstitial Macrophages 0.90
Cockroach immunotherapy modulates dominant T cell responses independent of allergen extract content 0.03
1 0.01
Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial 0.01
1 0.03
Pulsed Field Ablation as Initial Therapy for Persistent Atrial Fibrillation 0.03
1 0.71
Disproportionate impairment in diffusing capacity predicts pulmonary hypertension with an elevated pulmonary vascular resistance in COPD 0.71

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.